The REACH trial: a randomized controlled trial assessing the safety and effectiveness of the Spiration® Valve System in the treatment of severe emphysema
<b><i>Background:</i></b> Chronic obstructive pulmonary disease (COPD) has become a leading cause of morbidity and mortality in China, with tobacco smoke, air pollution, and occupational biohazards being the major risk factors. <b><i>Objectives:</i></b>...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Respiration
Year: 2018, Volume: 97, Issue: 5, Pages: 416-427 |
| ISSN: | 1423-0356 |
| DOI: | 10.1159/000494327 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1159/000494327 Verlag, Volltext: https://www.karger.com/Article/FullText/494327 
|
| Author Notes: | Shiyue Li, Guangfa Wang, Changhui Wang, Xinglin Gao, Faguang Jin, Huaping Yang, Baohui Han, Rui Zhou, Chengshui Chen, Liangan Chen, Chunxue Bai, Huahao Shen, Felix J. F. Herth, Nanshan Zhong |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1681803941 | ||
| 003 | DE-627 | ||
| 005 | 20230428191258.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191113r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000494327 |2 doi | |
| 035 | |a (DE-627)1681803941 | ||
| 035 | |a (DE-599)KXP1681803941 | ||
| 035 | |a (OCoLC)1341250716 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Li, Shiyue |d 1928-1996 |e VerfasserIn |0 (DE-588)136028829 |0 (DE-627)694006866 |0 (DE-576)300788207 |4 aut | |
| 245 | 1 | 0 | |a The REACH trial |b a randomized controlled trial assessing the safety and effectiveness of the Spiration® Valve System in the treatment of severe emphysema |c Shiyue Li, Guangfa Wang, Changhui Wang, Xinglin Gao, Faguang Jin, Huaping Yang, Baohui Han, Rui Zhou, Chengshui Chen, Liangan Chen, Chunxue Bai, Huahao Shen, Felix J. F. Herth, Nanshan Zhong |
| 264 | 1 | |c 2019 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: December 14, 2018 | ||
| 500 | |a Gesehen am 13.11.2019 | ||
| 520 | |a <b><i>Background:</i></b> Chronic obstructive pulmonary disease (COPD) has become a leading cause of morbidity and mortality in China, with tobacco smoke, air pollution, and occupational biohazards being the major risk factors. <b><i>Objectives:</i></b> The REACH trial is a multicenter, prospective, randomized controlled trial undertaken in China to assess the safety and effectiveness of the Spiration® Valve System (SVS) compared to standard medical care in COPD patients with severe emphysema. <b><i>Methods:</i></b> Patients with severe airflow obstruction, hyperinflation, and severe dyspnea with interlobar fissure integrity were evaluated for enrollment. A total of 107 subjects were randomized in a 2: 1 allocation ratio to either the treatment group (SVS valves and medical management) or the control group (medical management alone). <b><i>Results:</i></b> The 3-month primary endpoint showed statistically significant improvement in forced expiratory volume in 1 s in the treatment group compared to the control group (0.104 ± 0.18 vs. 0.003 ± 0.15 L, <i>p</i> = 0.001), with the difference being durable through 6 months. Statistically significant target lobe volume reduction was achieved at 3 months (mean change 684.4 ± 686.7 mL) and through 6 months (757.0 ± 665.3 mL). Exercise function and quality of life measures improved in the treatment group, but showed a deterioration in the control group. The serious adverse event (SAE) rate was 33% in the treatment group and 24.2% in the control group. The predominance of SAEs were acute exacerbations of COPD in both groups. There was 1 death in the control group and no deaths in the treatment group. <b><i>Conclusion:</i></b> The SVS represents a novel approach for the treatment of severe emphysema with a clinically acceptable risk-benefit profile. | ||
| 534 | |c 2018 | ||
| 700 | 1 | |a Wang, Guangfa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wang, Changhui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gao, Xinglin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jin, Faguang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yang, Huaping |e VerfasserIn |4 aut | |
| 700 | 1 | |a Han, Baohui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhou, Rui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Chengshui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Liangan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bai, Chunxue |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shen, Huahao |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herth, Felix |e VerfasserIn |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
| 700 | 1 | |a Zhong, Nanshan |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiration |d Basel : Karger, 1968 |g 97(2019), 5, Seite 416-427 |h Online-Ressource |w (DE-627)26551035X |w (DE-600)1464419-8 |w (DE-576)112815111 |x 1423-0356 |7 nnas |a The REACH trial a randomized controlled trial assessing the safety and effectiveness of the Spiration® Valve System in the treatment of severe emphysema |
| 773 | 1 | 8 | |g volume:97 |g year:2019 |g number:5 |g pages:416-427 |g extent:12 |a The REACH trial a randomized controlled trial assessing the safety and effectiveness of the Spiration® Valve System in the treatment of severe emphysema |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000494327 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/494327 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20191113 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1016095236 |a Herth, Felix |m 1016095236:Herth, Felix |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1016095236 |e 950000PH1016095236 |e 950900PH1016095236 |e 50000PH1016095236 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 13 | ||
| 999 | |a KXP-PPN1681803941 |e 3539681086 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Published online: December 14, 2018","Gesehen am 13.11.2019"],"relHost":[{"note":["Gesehen am 03.07.2024"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"97","text":"97(2019), 5, Seite 416-427","pages":"416-427","year":"2019","issue":"5","extent":"12"},"id":{"eki":["26551035X"],"issn":["1423-0356"],"zdb":["1464419-8"]},"title":[{"title":"Respiration","subtitle":"international journal of thoracic medicine","title_sort":"Respiration"}],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"1968","dateIssuedDisp":"1968-","publisher":"Karger"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["Vol. 25, no. 1 (1968)-"],"language":["eng"],"disp":"The REACH trial a randomized controlled trial assessing the safety and effectiveness of the Spiration® Valve System in the treatment of severe emphysemaRespiration","recId":"26551035X"}],"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.1159/000494327"],"eki":["1681803941"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"The REACH trial","subtitle":"a randomized controlled trial assessing the safety and effectiveness of the Spiration® Valve System in the treatment of severe emphysema","title":"The REACH trial"}],"language":["eng"],"person":[{"role":"aut","display":"Li, Shiyue","given":"Shiyue","family":"Li"},{"role":"aut","family":"Wang","given":"Guangfa","display":"Wang, Guangfa"},{"role":"aut","family":"Wang","given":"Changhui","display":"Wang, Changhui"},{"given":"Xinglin","display":"Gao, Xinglin","family":"Gao","role":"aut"},{"display":"Jin, Faguang","given":"Faguang","family":"Jin","role":"aut"},{"role":"aut","given":"Huaping","display":"Yang, Huaping","family":"Yang"},{"role":"aut","given":"Baohui","display":"Han, Baohui","family":"Han"},{"role":"aut","family":"Zhou","given":"Rui","display":"Zhou, Rui"},{"role":"aut","family":"Chen","given":"Chengshui","display":"Chen, Chengshui"},{"role":"aut","display":"Chen, Liangan","given":"Liangan","family":"Chen"},{"family":"Bai","display":"Bai, Chunxue","given":"Chunxue","role":"aut"},{"role":"aut","family":"Shen","display":"Shen, Huahao","given":"Huahao"},{"family":"Herth","given":"Felix","display":"Herth, Felix","role":"aut"},{"role":"aut","given":"Nanshan","display":"Zhong, Nanshan","family":"Zhong"}],"name":{"displayForm":["Shiyue Li, Guangfa Wang, Changhui Wang, Xinglin Gao, Faguang Jin, Huaping Yang, Baohui Han, Rui Zhou, Chengshui Chen, Liangan Chen, Chunxue Bai, Huahao Shen, Felix J. F. Herth, Nanshan Zhong"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"recId":"1681803941"} | ||
| SRT | |a LISHIYUEWATHEREACHTR2019 | ||